Long Term Care Journal
Friday, August 17, 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder - FDA Press Releases
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
from Food and Drug Administration--Press Releases https://ift.tt/2Mu9W53
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment